Cite

HARVARD Citation

    Gooderham, M. et al. (2019). Incidence of serious gastrointestinal events among tildrakizumab‐treated patients with psoriasis. Journal of the European Academy of Dermatology and Venereology. pp. e350-e352. [Online]. 
  
Back to record